Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

OBJECTIVES: Patients with rheumatoid arthritis (RA) are at increased risk of lymphoma compared with the general population. There are concerns that tumour necrosis factor inhibitors (TNFi) may exacerbate this risk. However, since the excess risk of lymphoma in RA is related to the cumulative burden...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Rheum Dis
Auteurs principaux: Mercer, Louise K, Galloway, James B, Lunt, Mark, Davies, Rebecca, Low, Audrey L S, Dixon, William G, Watson, Kath D, Symmons, Deborah P M, Hyrich, Kimme L
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2017
Sujets:
Clinical and Epidemiological Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446004/
https://ncbi.nlm.nih.gov/pubmed/27502891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2016-209389
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires